Search Results By Date:
Showing 811 - 825 of 870 results
  • Rezkalla SH, Kloner RA.. (1989 March). Management strategies in viral myocarditis. Am Heart J. 117(3):706-708.
    PubMed ID: 2645754
  • Rezkalla SH, Kloner RA., Khaw BA, Haber E, Fallon JT, Smith F, Khatib R. (1989 February). Detection of experimental myocarditis by monoclonal antimyosin antibody, Fab fragment. Am Heart J. 117(2):391-395.
    PubMed ID: 2916411
  • Mazza JJ, Mueller-Rizner NJ, Roberts RC. (1989). Multiple generations of inherited antithrombin III (AT-III) deficiency. BLOOD. 74(Suppl 1):393a.
  • Mazza JJ, Reding DJ. (1989). Hematopoietic growth factors: current use and future potential. Southern J Med.
  • Campbell CA, Rezkalla SH, Kloner RA., Turi ZG. (1989). Electrocardiographic findings: regional myocardial blood flow and infarct size during 90 minute inflation of autoperfusion catheter. J Am Coll Cardiol. 14 :1045-1050.
  • Rezkalla SH, Turi ZG, Keedy D, Precevski P, Kloner RA.. (1989). Left main coronary angioplasty in a sheep model using a new left main autoperfusion balloon catheter. J Invasive Cardiology. 1 :199-205.
  • Rezkalla SH, Boden WE, Kloner RA.. (1989). Identification and management of patients at risk for myocardial infarction extension. Practical Cardiology. 15 :50-59.
  • Cassileth PA, Harrington DP, Hines JD, Oken MM, Mazza JJ, McGlave PB,...O'Connell MJ. (1988 April). Maintenance chemotherapy prolongs remission duration in adult acute nonlymphocytic leukemia. J Clin Oncol. 6(4):583-587.
    PubMed ID: 3282032
  • Kay NE, Oken MM, Mazza JJ, Bradley EC. (1988). Evidence for tumor reduction in refractory or relapsed B-CLL patients with infusional interleukin-2. Nouv Rev Fr Hematol. 30(5-6):475-478.
    PubMed ID: 3265509
  • Workinger MS. (1988). Feeding Disorders in the Infant and Young Child. In: Yoder D., Kent R. (Ed.), Decision Making in Speech-Language Pathology Philadelphia: BC Decker, Inc..
  • Hines JD, Mazza JJ, Oken MM, Adelstein DJ, Keller AM, Bennett JM, O'Connell MJ. (1987 June). Prolonged survival after high-dose cytosine arabinoside and amsacrine induction in patients with previously untreated de novo acute nonlymphocytic leukemia. Semin Oncol. 2(Suppl 1):37-39.
    PubMed ID: 3296207
  • Cassileth PA, Begg CB, Silber R, Spiers AS, Burkart P, Scharfman W,...Oken MM [including Mazza JJ.] (1987 February). Prolonged unmaintained remission after intensive consolidation therapy in adult acute nonlymphocytic leukemia. Cancer Treat Rep. 71(2):137-140.
    PubMed ID: 3802110
  • Cassileth PA, Andersen J, Tsung L, Hoagland HC, Mazza JJ, Bennett JM,...Eastern Cooperative Oncology Group. (1987). Systemic high-dose cytarabine (HDARAC) provides effective central nervous system (CNS) prophylaxis in adult acute lymphocytic leukemia (ALL). BLOOD. 70 :225a.
  • Mazza JJ, Rushing DA, Friedenberg WR, Banerjee TK, Gehlsen JA. (1987). Myelodysplasia and acute leukemia following dibromodulcitol therapy. BLOOD. 70 :204a.
  • Cassileth PA, Andersen J, Hoagland J, Mazza JJ, Bennett JM, O'Connell MJ. (1987). Efficacy of high dose cytarabine (HDARAC) in initial therapy of adult acute lymphocytic leukemia (ALL). Proceedings of the American Society of Clinical Oncologists. 6 :158.